Copyright  2018 Advantagene, Inc.  All rights reserved. Made by AFP.    Terms of use | Privacy policy


May 19, 2011 - Advantagene announces SPA Agreement with FDA

February 6, 2013 - An interview featuring Charles King, one of our prostate clinical trial patients treated in Philadelphia, PA.

February 11, 2013 - An interview with Dr. Mark Buyyounouski, the principal investigator  for our prostate clinical trial at the Fox Chase Cancer Center, Philadelphia, PA.

March 14, 2014 - An interview with Dr. Shawn Zimberg, the principal investigator for our prostate cancer trial at Advanced Radiation Centers of New York (ARC) in metropolitan New York

May 29, 2013 - An interview with a ProstAtak™ study participant and with Dr. Tom Schroeder, the principal investigator for our prostate cancer trial at University of New Mexico, Albuquerque, NM

December 19, 2011 - Anti-cancer vaccines emerging ( The Boston Globe )

October 23, 2014 - Reducing Recurrence With a New Prostate Cancer Vaccine

October 22, 2014 - Newton Company Develops Prostate Cancer Vaccine (WBZ-TV 4, Boston, MA)

November 20, 2014 - Houston Doctor, Patient Lead the Way in Cancer Vaccine Study (KPRC-TV 2, Houston, TX)

May 26, 2015 - Massachusetts-based company to present at Global Health Care Conference

May 27, 2015 - Massachusetts-based company to present positive clinical study of engineered virus to fight brain cancer

June 1, 2015 - ASCO Meeting 2015 - Gene Therapy Shows Early Promise Against Deadly Brain Cancer

November 15, 2015 - Houston Chronicle front page story about GMCI™ brain tumor study- patient alive more than 9 years after treatment is featured

March 4, 2016 - Advantagene to present at Investor Conference

April 8, 2016 - Advantagene to present at Jefferies Immuno-Oncology Summit

April 11, 2016 - Advantagene to present at 15 Annual Needham Healthcare Conference



May 16, 2016 - Advantagene Launches “Proactive Surveillance™” Clinical Study in Patients with Localized Prostate Cancer Choosing Active Surveillance


June 4, 2016 -  Advantagene Releases Promising Clinical Data of its Novel Immunotherapy in Lung Cancer Patients at ASCO 2016

June 15, 2016 - Advantagene names Glenn Mattes SVP and Chief Operating Officer

September 12, 2016 - Advantagene Closes $14.2MM Series A

November 04, 2016 - Daniel Giroux Joins Advantagene as Vice President, Manufacturing

January 25, 2017 - Gregory J. Gailius Joins Advantagene Board of Directors as Chairman of Audit Committee

April 03, 2017 - Advantagene to present at the 16 Annual Needham Healthcare Conference

June 27 , 2017 - Advantagene Launches Clinical Study in Patients with NSCLC

October 5, 2017 - Edward J. Benz Jr., M.D., President and CEO Emeritus of Dana-Farber Cancer Institute, joins Advantagene Board of Directors

January 22, 2018 - Advantagene Announces the Publication of Preclinical Study Supporting a Combination Immune Therapy Approach for the Treatment of Glioblastoma